HR - Drugs & Alcohol
Navigating Cannabis Rescheduling: Key Insights for Healthcare
Earlier this year, the DEA responded to President Biden’s directive to reschedule cannabis from Schedule I to Schedule III of the Controlled Substances Act. This pivotal change, if finalized, would reclassify marijuana as a drug with moderate to low potential for dependence, strictly for medical use
This article was originally published by Jackson Lewis P.C.. Click below to read the full article on their site.
Read full articleOpens jacksonlewis.com
Content provided by Jackson Lewis P.C.. For informational purposes only — not legal advice. More from Jackson Lewis P.C. →